Gut Metagenome as a Potential Diagnostic and Predictive Biomarker in Slow Transit Constipation

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-4-3
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Tian H, Ye C, Yang B, Cui J, Zheng Z, Wu C, Zhou S, Lv X, Qin N, Qin H, Li N, Chen Q
Journal
Frontiers in medicine
Year
2021
Keywords:
biomarker, diagnostic, gut microbiome, metagenomic analysis, pathogenesis, slow transit constipation
Slow transit constipation (STC) is one of the most frequent gastrointestinal diagnoses. In this study, we conducted a quantitative metagenomics study in 118 Chinese individuals. These participants were divided into the discovery cohort of 50 patients with STC and 40 healthy controls as well as a validation cohort of 16 patients and 12 healthy controls. We found that the intestinal microbiome of patients with STC was significantly different from that of healthy individuals at the phylum, genus, and species level. Patients with STC had markedly higher levels of Alistipes and Eubacterium and lower abundance of multiple species belonging to the Roseburia genus. Patients with STC gene expression levels and the Kyoto Encyclopedia of Genes and Genomes (KEGG) orthology pathway (such as fatty acid biosynthesis, butanoate metabolism, and methane metabolism pathways) enrichment were also substantially different from those of healthy controls. These microbiome and metabolite differences may be valuable biomarkers for STC. Our findings suggest that alteration of the microbiome may lead to constipation by changing the levels of microbial-derived metabolites in the gut. Above findings may help us in the development of microbial drugs.

Experiment 1


Reviewed Marked as Reviewed by Svetlana up on 2025-4-3

Curated date: 2025/03/22

Curator: Tosin

Revision editor(s): Tosin

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Chronic constipation Chronic constipation,Infrequent bowel movements,chronic constipation
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Slow transit constipation (STC) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with slow transit constipation (STC)
Group 0 sample size Number of subjects in the control (unexposed) group
52
Group 1 sample size Number of subjects in the case (exposed) group
66

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.1
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-3

Curated date: 2025/03/22

Curator: Tosin

Revision editor(s): Tosin

Source: Figure 1, Table S2, Table S3, Table S4, Table 3

Description: Differentially abundant taxa between slow transit constipation (STC) patients and healthy controls

Abundance in Group 1: increased abundance in Slow transit constipation (STC) group

NCBI Quality ControlLinks
Actinomycetota
Akkermansia
Akkermansia muciniphila
Alistipes
Anaerotruncus
Bacillota
Bifidobacterium
Clostridiales bacterium 1_7_47FAA
Clostridium
Eggerthella
Eggerthella lenta
Enterocloster asparagiformis
Enterocloster citroniae
Erysipelotrichaceae bacterium 21_3
Erysipelotrichaceae bacterium 2_2_44A
Flavonifractor
Gordonibacter
Gordonibacter pamelaeae
Holdemania
Hungatella hathewayi
Lachnospiraceae bacterium 3_1_57FAA_CT1
Lachnospiraceae bacterium 7_1_58FAA
Odoribacter
Oscillibacter
Parabacteroides
Parabacteroides goldsteinii
Parabacteroides merdae
Ruminococcus bromii
Subdoligranulum
Verrucomicrobiota
[Clostridium] leptum
[Clostridium] symbiosum
unclassified Eggerthella
unclassified Eubacteriales
unclassified Lachnospiraceae
unclassified Oscillibacter
unclassified Subdoligranulum

Revision editor(s): Tosin

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-3

Curated date: 2025/03/22

Curator: Tosin

Revision editor(s): Tosin

Source: Figure 1, Table S2, Table S3, Table S4, Table 3

Description: Differentially abundant taxa between slow transit constipation (STC) patients and healthy controls

Abundance in Group 1: decreased abundance in Slow transit constipation (STC) group

NCBI Quality ControlLinks
Bacteroidota
Enterobacter
Fusobacteriota
Lachnospiraceae bacterium 5_1_57FAA
Megamonas
Methanobacteriota
Oxalobacter
Roseburia intestinalis
Subdoligranulum sp. 4_3_54A2FAA
Synergistota
[Clostridium] scindens
unclassified Oscillospiraceae
Coprobacillus_sp_29_1Coprobacillus_sp_29_1

Revision editor(s): Tosin